Fosaprepitant 150 mg/5mL (Fosaprepitant dimeglumine INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 150 mg/5mL

Fosaprepitant 150 mg/5mL is a lyophilized powder for solution used for intravenous administration. It is commonly associated with managing nausea and vomiting, particularly in cancer patients undergoing chemotherapy. This medication is manufactured by Camber Pharmaceuticals, Inc. in the USA.

Strength

150 mg/5mL

Pack Size

1 VIAL, SINGLE-DOSE in 1 CARTON (31722-165-31) / 5 mL in 1 VIAL, SINGLE-DOSE

Manufacturer / TM Owner

Camber Pharmaceuticals, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Fosaprepitant 150 mg/5mL is primarily used to prevent nausea and vomiting caused by chemotherapy. It works by blocking substances in the body that can trigger these symptoms. This medication is often administered as part of a combination therapy to enhance its effectiveness. Patients and healthcare providers may explore fosaprepitant uses to understand its role in managing chemotherapy-induced nausea and vomiting.

Side Effects

Common effects of Fosaprepitant 150 mg/5mL may include fatigue, headache, and diarrhea. Some patients might experience changes in taste or constipation. These effects can vary from person to person and are not exhaustive. It is important to consult with a healthcare provider for personalized information.

Precautions & Warnings

Fosaprepitant 150 mg/5mL should be handled with care, ensuring it is stored and administered correctly. It is crucial to follow the prescribed dosage and administration guidelines provided by a healthcare professional. Patients with known allergies to any of the ingredients should avoid using this medication. Always inform your healthcare provider about any pre-existing conditions or medications you are taking.

Avoid Interactions

Fosaprepitant 150 mg/5mL may interact with other medications, including those metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain foods may also affect how this medication works. Always consult with a healthcare provider for personalized advice.

Frequently Asked Questions

Fosaprepitant 150 mg/5mL is used to prevent nausea and vomiting, particularly in cancer patients undergoing chemotherapy.

Fosaprepitant 150 mg/5mL is administered intravenously after reconstitution of the lyophilized powder.

Common effects may include fatigue, headache, and diarrhea. Some patients might experience changes in taste or constipation.

Fosaprepitant 150 mg/5mL may interact with other medications, so it is important to consult a healthcare provider before combining it with other treatments.

Precautions include following the prescribed dosage, informing your healthcare provider about allergies, and discussing any pre-existing conditions or other medications you are taking.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.